Ehesan U. Sharif

648 citations

26 papers · 370 indexed · h-index 10

Physiology top 10%
- Adenosine and Purinergic Signaling 7
Organic Chemistry top 10%
- Synthetic Organic Chemistry Methods 6
- Carbohydrate Chemistry and Synthesis 6
- Click Chemistry and Applications 4
- Catalytic Cross-Coupling Reactions 2
Toxicology top 10%
Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 5
Biotechnology
Biomedical Engineering
- Nanoplatforms for cancer theranostics 5
Molecular Biology
- Chemical Synthesis and Analysis 4

Co-authors: George A. O’Doherty Novruz G. Akhmedov Mingde Shan Barry M. Trost Hua-Yu Leo Wang Shiyan Xu Jay P. Powers Manmohan R. Leleti
Cited by: Physiology Organic Chemistry Toxicology
Journals: Journal of the American Chemical Society (2 papers)Organic Process Research & Development (2 papers)Chemical Science (2 papers)
Partner nations: United States Qatar Mexico

In The Last Decade

Ehesan U. Sharif

24 papers receiving 357 citations

Peers

Countries citing papers authored by Ehesan U. Sharif

Since Specialization

Citations

This map shows the geographic impact of Ehesan U. Sharif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehesan U. Sharif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehesan U. Sharif more than expected).

Fields of papers citing papers by Ehesan U. Sharif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehesan U. Sharif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehesan U. Sharif. The network helps show where Ehesan U. Sharif may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ehesan U. Sharif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ehesan U. Sharif Line = papers co-authored together Ehesan U. Sharif links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments Frontiers in Immunology ·Bahman Farmān,何彩升,Sumaira Anjum,Humera Kausar,Ehesan U. Sharif,Wisam Nabeel Ibrahim	2025	2
2	Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors Journal of Medicinal Chemistry ·Peter A. Samarin,Joong-Yub Shin,J.Kenneth Matejka,Manjunath Lamani,К.В. Миронова,Ehesan U. Sharif,Joice Thomas,Pradeep Nareddy,Gang Zhao,Yu Chen,Xiaoning Zhao,David A. Green,Hans-Heiner Warsaw,Lixia Jin,Ramazan M. Gilmanov,Ester Fernández‐Salas,Jay P. Powers,Manmohan R. Leleti,Dillon H. Miles	2025	1
3	Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment? Frontiers in Oncology ·Yo Hara,Mahmoud H. A. Mohamed,Subrata Kumar Majumder,Ehesan U. Sharif,Wisam Nabeel Ibrahim	2024	19
4	Development of a Robust and Scalable Synthetic Route for a Potent and Selective Isoindolinone PI3Kγ Inhibitor Organic Process Research & Development ·Artur K. Mailyan,Guillaume Mata,Dillon H. Miles,Ehesan U. Sharif,Manmohan R. Leleti,Jay P. Powers,Jenna L. Jeffrey	2022	6
5	Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors Journal of Medicinal Chemistry ·Ehesan U. Sharif,Jarosław Kalisiak,Kenneth V. Lawson,Dillon H. Miles,Giovanny Andrés Avila Bohórquez,Erick A. Lindsey,Brandon R. Rosen,Laurent Debien,Ada Chen,Xiaoning Zhao,Stephen W. Young,Nigel P.C. Walker,Norbert Sträter,Emma Rose Scaletti,Lixia Jin,Guifen Xu,Manmohan R. Leleti,Jay P. Powers	2021	26
6	Synthesis of O‐linked Cyclitol Analogues of Gilvocarcin M and Antibacterial Activity Israel Journal of Chemistry ·Ehesan U. Sharif,Pei‐Yong Shi,George A. O’Doherty	2021	1
7	Development of a Scalable and Practical Synthesis of AB928, a Dual A_2a/A_2b Receptor Antagonist Organic Process Research & Development ·Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Jenna L. Jeffrey,Laurent Debien,Jay P. Powers,Manmohan R. Leleti	2020	3
8	Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression Cancer Immunology Research ·Daniel DiRenzo,谢亚峰 XIE Ya-feng,Joanne B.L. Tan,Dillon H. Miles,Manmohan R. Leleti,Timothy Park,Ferdie Soriano,M. Yücekaya,Jenna L. Jeffrey,Ehesan U. Sharif,Brandon R. Rosen,Ulrike Schindler,Jay P. Powers,Matthew J. Walters	2019	7
9	New Catalytic Asymmetric Formation of Oxygen Heterocycles Bearing Nucleoside Bases at the Anomeric Carbon Journal of the American Chemical Society ·Barry M. Trost,Shiyan Xu,Ehesan U. Sharif	2019	16
10	Final results of the phase I study in healthy volunteers of AB928, a dual antagonist of the A2aR and A2bR adenosine receptors being studied as an activator of anti-tumor immune response Annals of Oncology ·Lisa Seitz,M. Ramirez-Mella,Manmohan R. Leleti,Jay P. Powers,Brandon R. Rosen,Dillon H. Miles,Ehesan U. Sharif,K Gopi,Glen Satria,S. R. Young,A. P. M.,Ronald Angerbauer,Joyson Karakunnel,Walter Nicolaw Romero Vega	2018	2
11	AB928, a dual antagonist of the A 2a R and A 2b R adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy European Journal of Cancer ·Ulrike Schindler,Lisa Seitz,M. Ramirez-Mella,谢亚峰 XIE Ya-feng,Joanne B.L. Tan,Daniel DiRenzo,F Yin,Manmohan R. Leleti,Brandon R. Rosen,Dillon H. Miles,Lixia Jin,HJ Moss,S. R. Young,Ferdie Soriano,A. P. M.,Joyson Karakunnel,Ehesan U. Sharif,罗泳臻,Walter Nicolaw Romero Vega	2018	5
12	Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer Cancer Research ·Walter Nicolaw Romero Vega,Joanne B.L. Tan,Annette Becker,Fangfang Yi,Daniel Carvalho Fonseca,Manmohan R. Leleti,Brandon R. Rosen,Ehesan U. Sharif,Laurent Debien,Steve Young,順一星川,Stefan Garrido-Shaqfeh,Juan C. Jaén,Jay P. Powers	2017	9
13	Ru-catalyzed sequence for the synthesis of cyclic amido-ethers Chemical Science ·Barry M. Trost,Ehesan U. Sharif,Chloé Giroud	2016	5
14	ChemInform Abstract: Ruthenium‐Catalyzed Multicomponent Reactions: Access to α‐Silyl‐β‐Hydroxy Vinylsilanes, Stereodefined 1,3‐Dienes, and Cyclohexenes. ChemInform ·Barry M. Trost,Dennis C. Koester,Ehesan U. Sharif	2016	1
15	Denovo asymmetric synthesis of the mezzettiaside family of natural products via the iterative use of a dual B-/Pd-catalyzed glycosylation Chemical Science ·Juliana Sanches Venturini,Ehesan U. Sharif,Novruz G. Akhmedov,George A. O’Doherty	2014	77
16	Merremoside D: De Novo Synthesis of the Purported Structure, NMR Analysis, and Comparison of Spectral Data Organic Letters ·Ehesan U. Sharif,Hua-Yu Leo Wang,Novruz G. Akhmedov,George A. O’Doherty	2013	29
17	C3′/C4′‐Stereochemical Effects of Digitoxigenin α‐L‐/α‐D‐Glycoside in Cancer Cytotoxicity ChemMedChem ·佐緒理山口,Iskandar Kanta Dinata,Ehesan U. Sharif,Maria Agheb,Novruz G. Akhmedov,George A. O’Doherty	2012	25
18	Biosynthesis and Total Synthesis Studies on the Jadomycin Family of Natural Products European Journal of Organic Chemistry ·Ehesan U. Sharif,George A. O’Doherty	2012	29
19	Roles of the Synergistic Reductive O-Methyltransferase GilM and of O-Methyltransferase GilMT in the Gilvocarcin Biosynthetic Pathway Journal of the American Chemical Society ·Nidhi Tibrewal,احسان فلاحتی,Steven G. Van Lanen,Ehesan U. Sharif,George A. O’Doherty,Jürgen Rohr	2012	19
20	Total Synthesis of Jadomycin A and a Carbasugar Analogue of Jadomycin B Angewandte Chemie International Edition ·Mingde Shan,Ehesan U. Sharif,George A. O’Doherty	2010	59

About Ehesan U. Sharif

Ehesan U. Sharif is a scholar working on Physiology, Organic Chemistry and Pharmacology, having authored 26 papers that have together received 370 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (7 papers), Synthetic Organic Chemistry Methods (6 papers), Carbohydrate Chemistry and Synthesis (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Nanoplatforms for cancer theranostics (5 papers), Click Chemistry and Applications (4 papers), Chemical Synthesis and Analysis (4 papers) and Catalytic Cross-Coupling Reactions (2 papers). The work is most often cited by research in Physiology (48 citations), Organic Chemistry (252 citations) and Toxicology (21 citations). Ehesan U. Sharif has collaborated with scholars based in United States, Qatar and Mexico. Frequent co-authors include George A. O’Doherty, Novruz G. Akhmedov, Mingde Shan, Barry M. Trost, Hua-Yu Leo Wang, Shiyan Xu, Jay P. Powers, Manmohan R. Leleti, Dillon H. Miles and Brandon R. Rosen. Their work appears in journals such as Journal of the American Chemical Society, Organic Process Research & Development, Chemical Science, Journal of Medicinal Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact